741 - Xolair: The First Drug For Severe Food Allergies episode artwork

EPISODE · Apr 3, 2024 · 10 MIN

741 - Xolair: The First Drug For Severe Food Allergies

from Public Health On Call · host Johns Hopkins Bloomberg School of Public Health

Xolair is the first FDA-approved therapy to prevent severe and potentially life-threatening reactions in adults and children who are allergic to dairy, eggs, wheat, nuts and other foods. Dr. Robert Wood, the director of pediatric allergy and immunology at Johns Hopkins, talks with Lindsay Smith Rogers about this drug that has the potential to make life a little easier for patients and parents of children with severe allergies.

Episode metadata supplied by the publisher feed · Published Apr 3, 2024

Embed this episode

Ready to play

741 - Xolair: The First Drug For Severe Food Allergies

0:00 10:52

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Public Health On Call?

This episode is 10 minutes long.

When was this Public Health On Call episode published?

This episode was published on April 3, 2024.

Can I download this Public Health On Call episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!